Tuesday, October 30, 2012

An Invitation to join Data Driven Drug Development from the CIO of Cubist Pharmaceuticals

A few words from Matt Dattilo, CIO, Cubist Pharmaceuticals, the chair for the Data Driven Drug Development Event taking place January 28-29, 2013 in Philadelphia, PA.  If you'd like to join us, register today and mention code P1715BLOG and save 15% off the standard rate!

 Matt Dattilo, CIO, Cubist Pharmaceuticals
For those of us who work in information management in the pharmaceutical industry, we have seen some major changes in the last few years as the amount of data and our ability to use the data available has grown exponentially -- and will continue to do so. Being able to manage and mine that data more effectively can reduce the cost and length of time to discover and develop new life saving/improving therapies. Therefore, we’re finding we can’t keep the business units and the IT department segregated any longer. Data now has measureable economic value, and so we have seen a shift towards more integrated R&D and IT divisions to take advantage of that value and drive faster and earlier decision making.

It’s an exciting time to be in the pharmaceutical information business.

I would like to invite you to attend IIR’s inaugural Data-Driven Drug Development (D4), taking place on January 28-29 in Philadelphia. As you may have heard, I have the honor of being the chairman for this groundbreaking event and I am truly excited for those in the industry like us to have this opportunity to collaborate on how to bridge the knowledge gap between R&D and IT.

Without a doubt, one of the things that really intrigued me about this program is that the sessions are led by THE leading big pharma executives in the industry. When you download the agenda, you’ll see sessions including:

Angela Yochem, CTO of Astrazeneca will explain why AZ is on the information management bandwagon, reinventing IT to make it a strategic asset to the business
Ramzi Najm, Allergan’s VP of Information Technology Management will divulge how he was able to get buy-in from the executive leadership for a data-driven approach to company operations
Brian Ellerman, Head of Information Solutions at Sanofi-Aventis will discuss strategies to maximize external collaboration through IT

These issues aren’t being addressed anywhere else. For more information about D4, please visit the website.

Thank you very much and I look forward to seeing you in January in Philly!

All the best,

Matt Dattilo,
CIO, Cubist Pharmaceuticals
Chairperson, Data-Driven Drug Development

Share this article with your social network, just click below to share now!

No comments :

Post a Comment